StonvexLoading…
StonvexStonvexStonvexCore line items from FITB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $577.00M | $589.00M | $600.00M | $559.00M |
Operating Income | $2.99B | $3.09B | $3.52B | $1.80B |
Net Income | $2.35B | $2.45B | $2.77B | $1.43B |
EPS (Diluted) | $3.22 | $3.35 | $3.73 | $1.83 |
Total Assets | $214.57B | $207.45B | $211.12B | $204.68B |
Total Liabilities | $195.40B | $190.13B | $188.91B | $181.57B |
Cash & Equivalents | $3.14B | $3.47B | $2.99B | $3.15B |
Free Cash Flow OCF − CapEx | $4.02B | $6.08B | $2.40B | $66.00M |
Shares Outstanding | 681.12M | 683.39M | 682.78M | 712.76M |